Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$16.8 million.

  • Phibro Animal Health's Net Cash Flow fell 18884.43% to -$16.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$13.0 million, marking a year-over-year decrease of 13438.48%. This contributed to the annual value of -$1.4 million for FY2025, which is 10438.22% down from last year.
  • As of Q4 2025, Phibro Animal Health's Net Cash Flow stood at -$16.8 million, which was down 18884.43% from $4.6 million recorded in Q3 2025.
  • Phibro Animal Health's Net Cash Flow's 5-year high stood at $23.1 million during Q4 2021, with a 5-year trough of -$31.2 million in Q1 2023.
  • Its 5-year average for Net Cash Flow is $1.3 million, with a median of $3.0 million in 2022.
  • Per our database at Business Quant, Phibro Animal Health's Net Cash Flow skyrocketed by 75551.26% in 2022 and then tumbled by 101017.27% in 2024.
  • Phibro Animal Health's Net Cash Flow (Quarter) stood at $23.1 million in 2021, then plummeted by 137.13% to -$8.6 million in 2022, then rose by 6.7% to -$8.0 million in 2023, then soared by 336.3% to $18.9 million in 2024, then plummeted by 188.84% to -$16.8 million in 2025.
  • Its Net Cash Flow was -$16.8 million in Q4 2025, compared to $4.6 million in Q3 2025 and $6.5 million in Q2 2025.